Aulos Bioscience, Inc.
1 clinical trials · Sponsor
◉ Watch Aulos Bioscience, Inc.
| Record | Firm | Date |
|---|---|---|
| Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer (NCT05267626) | Aulos Bioscience, Inc. | 2022-04-04 |
Track Aulos Bioscience, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.